Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Jim Van Meerten

This ‘Strong Buy’ Pharma Stock Is Surging to New Highs

  • Insmed (INSM) shows strong technical momentum, hitting a new 52-week high on Aug. 18.
  • INSM has a 100% “Buy” opinion from Barchart with impressive recent gains.
  • Revenue is projected to grow nearly 29% this year and 126% next year, with earnings growth expected to accelerate in 2026.
  • Wall Street analysts are mostly bullish, but there is a wide range of price targets on INSM here. 

Today’s Featured Stock

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.